Interferon-λ Genetic Variations and Hepatitis C: Yet to be Discovered.
作者信息
Keshvari Maryam, Sharafi Heidar
机构信息
Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, IR Iran ; Middle East Liver Diseases (MELD) Center, Tehran, IR Iran.
Middle East Liver Diseases (MELD) Center, Tehran, IR Iran.
出版信息
Hepat Mon. 2014 May 10;14(5):e19433. doi: 10.5812/hepatmon.19433. eCollection 2014 May.
Abstract
摘要
相似文献
1
Interferon-λ Genetic Variations and Hepatitis C: Yet to be Discovered.干扰素-λ基因变异与丙型肝炎：有待发现
Hepat Mon. 2014 May 10;14(5):e19433. doi: 10.5812/hepatmon.19433. eCollection 2014 May.
2
Genetic Polymorphisms within Interferon-λ Region and Interferon-λ3 in the Human Pathophysiology: Their Contribution to Outcome, Treatment, and Prevention of Infections with Hepatotropic Viruses.干扰素-λ 区域和人类病理生理学中的干扰素-λ3 内的遗传多态性：对嗜肝病毒感染的结局、治疗和预防的贡献。
Curr Med Chem. 2019;26(25):4832-4851. doi: 10.2174/0929867325666180719121142.
3
Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?系统评价与荟萃分析：干扰素 λ3 多态性是否可预测乙型肝炎感染中干扰素治疗的结局？
Aliment Pharmacol Ther. 2014 Mar;39(6):569-78. doi: 10.1111/apt.12631. Epub 2014 Jan 26.
4
Genetic polymorphism in IFNL4 and response to pegylated interferon-α and ribavirin in Japanese chronic hepatitis C patients.日本慢性丙型肝炎患者中IFNL4基因多态性与聚乙二醇化干扰素-α和利巴韦林治疗反应的关系
Tissue Antigens. 2014 Jan;83(1):45-8. doi: 10.1111/tan.12264.
5
Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.单核苷酸多态性rs117648444（P70S）导致的混杂因素影响慢性3型丙型肝炎病毒感染患者中干扰素λ基因座变异与干扰素-α-利巴韦林治疗反应的相关性。
J Interferon Cytokine Res. 2017 Aug;37(8):369-382. doi: 10.1089/jir.2017.0002. Epub 2017 Jul 20.
6
The Role of Interferon Lambda 3 Genetic Polymorphisms in Response to Interferon Therapy in Chronic Hepatitis B Patients: An Updated Meta-Analysis.干扰素λ3基因多态性在慢性乙型肝炎患者干扰素治疗反应中的作用：一项更新的荟萃分析。
Hepat Mon. 2016 Jun 29;16(7):e37534. doi: 10.5812/hepatmon.37534. eCollection 2016 Jul.
7
Impaired induction of interleukin 28B and expression of interferon λ 4 associated with nonresponse to interferon-based therapy in chronic hepatitis C.白细胞介素28B诱导受损及干扰素λ4表达与慢性丙型肝炎基于干扰素治疗无应答相关。
J Gastroenterol Hepatol. 2015 Jun;30(6):1075-84. doi: 10.1111/jgh.12902.
8
Association of interferon lambda-4 rs12979860 polymorphism with hepatocellular carcinoma in patients with chronic hepatitis C infection.慢性丙型肝炎感染患者中干扰素λ-4基因rs12979860多态性与肝细胞癌的关联
World J Hepatol. 2021 Jan 27;13(1):109-119. doi: 10.4254/wjh.v13.i1.109.
9
Interferon lambda-3 polymorphism and response to pegylated interferon in patients with hepatitis D.丁型肝炎患者中干扰素λ-3基因多态性与聚乙二醇干扰素治疗反应
Antivir Ther. 2015;20(5):529-33. doi: 10.3851/IMP2943. Epub 2015 Feb 10.
10
The correlation between hepatitis C core antigen and hepatitis C virus RNA levels with respect to human immunodeficiency virus status, hepatitis C virus genotype and interferon-lambda-4 polymorphism.丙型肝炎核心抗原与丙型肝炎病毒RNA水平在人类免疫缺陷病毒状态、丙型肝炎病毒基因型及干扰素-λ-4多态性方面的相关性。
Intervirology. 2015;58(2):73-9. doi: 10.1159/000370070. Epub 2015 Feb 13.
引用本文的文献
1
Impact of IFNL4 rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-α and Ribavirin in patients with congenital bleeding disorder and chronic hepatitis C.IFNL4基因rs12979860和rs8099917多态性对先天性出血性疾病合并慢性丙型肝炎患者接受聚乙二醇干扰素-α和利巴韦林治疗反应的影响
J Clin Lab Anal. 2017 Jul;31(4). doi: 10.1002/jcla.22063. Epub 2016 Oct 13.
本文引用的文献
1
The IFN-λ Genetic Polymorphism Association With the Viral Clearance Induced by Hepatitis C Virus Treatment in Pakistani Patients.巴基斯坦患者中IFN-λ基因多态性与丙型肝炎病毒治疗诱导的病毒清除的关联
Hepat Mon. 2014 Mar 9;14(3):e15076. doi: 10.5812/hepatmon.15076. eCollection 2014 Mar.
2
IL28B genotype and the expression of ISGs in normal liver.IL28B 基因型与正常肝脏中 ISGs 的表达。
Liver Int. 2013 Aug;33(7):991-8. doi: 10.1111/liv.12148. Epub 2013 Mar 24.
3
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.IFNL3（IL28B）上游的一种变体创造了一个新的干扰素基因 IFNL4，与丙型肝炎病毒清除能力受损有关。
Nat Genet. 2013 Feb;45(2):164-71. doi: 10.1038/ng.2521. Epub 2013 Jan 6.
4
IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection.IL28B 基因变异与丙型肝炎病毒基因型 3 感染患者的治疗反应。
Hepatology. 2011 Mar;53(3):746-54. doi: 10.1002/hep.24154.
5
IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy.IL28 变异影响干扰素刺激基因的表达和聚乙二醇干扰素及利巴韦林治疗。
J Hepatol. 2011 Jun;54(6):1094-101. doi: 10.1016/j.jhep.2010.09.019. Epub 2011 Feb 4.
6
Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients.IL28B 基因多态性在丙型肝炎病毒基因型 2 和 3 感染患者中的重要性。
J Hepatol. 2011 Mar;54(3):415-21. doi: 10.1016/j.jhep.2010.07.041. Epub 2010 Sep 22.
7
Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.肝组织干扰素刺激基因表达与白细胞介素 28B 基因多态性及慢性丙型肝炎干扰素治疗结局相关。
Gastroenterology. 2010 Aug;139(2):499-509. doi: 10.1053/j.gastro.2010.04.049. Epub 2010 Apr 29.
8
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.IL28B与慢性丙型肝炎α干扰素和利巴韦林治疗的反应相关。
Nat Genet. 2009 Oct;41(10):1100-4. doi: 10.1038/ng.447. Epub 2009 Sep 13.
9
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.IL28B全基因组与聚乙二醇化干扰素-α和利巴韦林治疗慢性丙型肝炎疗效的关联研究
Nat Genet. 2009 Oct;41(10):1105-9. doi: 10.1038/ng.449. Epub 2009 Sep 13.
Zotero 插件